These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8847041)

  • 1. gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.
    Van Thiel DH; Friedlander L; Malloy P; Wright HI; Gurakar A; Fagiuoli S; Irish W
    Hepatogastroenterology; 1995; 42(6):888-92. PubMed ID: 8847041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response.
    Mazzella G; Salzetta A; Casanova S; Morelli MC; Villanova N; Miniero R; Sottili S; Novelli V; Cipolla A; Festi D
    Dig Dis Sci; 1994 Apr; 39(4):866-70. PubMed ID: 7908624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
    Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
    Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment.
    Boucher E; Bourienne A; Adams P; Turlin B; Brissot P; Deugnier Y
    Gut; 1997 Jul; 41(1):115-20. PubMed ID: 9274482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to alpha interferon therapy in HCV chronic liver disease: role of hepatic fibrosis.
    Di Costanzo GG; Ascione A; Lanza AG; De Luca M; Bracco A; Lojodice D; Marsilia GM; Ferbo U
    Ital J Gastroenterol; 1996 Apr; 28(3):140-6. PubMed ID: 8789824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M; Block G; Finkelstein SD
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C and interferon alfa therapy: predictors of long term response.
    Jenkins PJ; Cromie SL; Bowden DS; Finch CF; Dudley FJ
    Med J Aust; 1996 Feb; 164(3):150-2. PubMed ID: 8628133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection.
    Lam NP; DeGuzman LJ; Pitrak D; Layden TJ
    Dig Dis Sci; 1994 Dec; 39(12):2660-4. PubMed ID: 7995193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough of interferon therapy.
    Scalori A; Ricci A; Bellati G; Colloredo G; Roffi L
    Am J Gastroenterol; 1996 Oct; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon therapy for chronic hepatitis C.
    Davis GL
    Baillieres Clin Gastroenterol; 1996 Jul; 10(2):289-98. PubMed ID: 8864035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
    Banner BF; Barton AL; Cable EE; Smith L; Bonkovsky HL
    Mod Pathol; 1995 Apr; 8(3):232-8. PubMed ID: 7542385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.